Bulletin of the Chemical Society of Japan p. 423 - 428 (2000)
Update date:2022-08-04
Topics:
Hasegawa, Tomoyuki
Yamamoto, Hisashi
(R)-2-Propyloctanoic acid has been developed as a novel therapeutic agent for Alzheimer's disease. A large-scale synthesis of this candidate was achieved by using Oppolzer's camphorsultam as a chiral auxiliary under improved conditions. It was essential for the successful synthesis of this compound to utilize a new removal method for the chiral source with a combination of tetrabutylammonium hydroxide and hydrogen peroxide. The present process afforded the desired product in high yield with high optical purity.
View MoreHangzhou Gangjin Chemical Co.,Ltd.(expird)
Contact:+86-571-85109780
Address:707 Zhejiang Minhang Bldg., No.290 Zhongshan North Road, Hangzhou 310003, China
Jiangsu Feymer Technology Co., Ltd.
Contact:+86-512-58110132
Address:Fenghuang Town, Zhangjiagang City, Jiangsu Province, China
Contact:+86-571-28186845
Address:Room 1224,Eastcom Mansion,398 Wensan Road,Hangzhou,310013 China
Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
Contact:886 2 2541 0022
Address:8 Fl., No. 11, Sec. 1, Chung Shan North Rd., Taipei, Taiwan R.O.C.
Doi:10.1246/cl.1998.863
(1998)Doi:10.1002/1522-2675(200206)85:6<1659::AID-HLCA1659>3.0.CO;2-D
(2002)Doi:10.1002/aoc.3298
(2015)Doi:10.1016/S0031-9422(98)00270-2
(1998)Doi:10.1002/hc.21415
(2018)Doi:10.1016/S0040-4020(98)00781-9
(1998)
